Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 CAD | +5.56% | +11.76% | +11.76% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mads Daugaard
PSD | President | - | 20-12-31 |
David Hyman
DFI | Director of Finance/CFO | - | - |
John Langlands
COO | Chief Operating Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 19-05-05 | |
Jeffrey Bacha
CHM | Chairman | 56 | 20-11-30 |
Dennis Brown
BRD | Director/Board Member | 74 | 21-03-24 |
Michael Liggett
BRD | Director/Board Member | - | 21-03-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,084,925 | 37,967,157 ( 54.17 %) | 0 | 54.17 % |
Company contact information
Rakovina Therapeutics, Inc.
999 West Broadway Suite 720
V5Z 1K5, Vancouver
+
http://www.rakovinatherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+11.76% | 4.89M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- RKV Stock
- Company Rakovina Therapeutics Inc.